Business

Rule 2.10 Announcement

Rule 2.10 Announcement.

articleCellbxhealth PlcJuly 18, 20083/company/cellbxhealth-plc/news/rule-210-announcement-75
Rule 2.10 Announcement

About this update from Cellbxhealth Plc

[{"type":"text","content":"\n RNS Number : 4559Z Angle PLC 18 July 2008  \n \nANGLE plc\n18 July 2008\n\nNot for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan or the Republic of Ireland\n\nANGLE plc ('ANGLE' or the 'Company')\n\nRule 2.10 announcement\n\nIn accordance with Rule 2.10 of the City Code on Takeovers and Mergers, the Company confirms that it has 27,132,931 ordinary shares of 10 pence each in issue. \n\nThe ISIN reference for these securities is GB0034330679.\n\nEnds\n\nContact:\n\n\n\n\n\nAndrew Newland, Chief Executive\nIan Griffiths, Finance Director\nANGLE plc\n\n\n\n\n\n+ 44 (0) 1483 295830\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMark Connelly/ Stewart Wallace\nCollins Stewart Europe Limited\n\n\n\n\n\n                  + 44 (0) 207 523 8350\n\n\n\n\n\nCollins Stewart Europe Limited ('Collins Stewart') which is regulated in the United Kingdom by The Financial Services Authority is acting for the Company in relation to the matters described in this announcement and is not advising any other person, and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to customers of Collins Stewart or for providing advice in relation to the matters described in this announcement.\n\nDealing disclosure requirements\n   \nUnder the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the 'Code'), if any person is, or becomes, 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Braveheart or the Company, all 'dealings' in any 'relevant securities' of Braveheart or the Company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities'...

More updates from Cellbxhealth Plc